Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Alexandra Garcilazo-Reyes

Showing results (1-10 of 4) with videos related to

Pageof 1
Sort By:
Oncology (Williston Park, N.Y.)|July 2, 2020
Which Larynx-Preservation Strategy Would Be Best for a Patient With Resectable, Locally Advanced, Hypopharynx Squamous Cell Carcinoma?Nora Sobrevilla-Moreno, Javier I Altamirano-Garcia, Martin Granados-Garcia, et al.
JCO Global Oncology|September 29, 2025
Cascade Testing Among Patients With Breast Cancer: Current Situation and Challenges in Latin AmericaRosa María Alvarez-Gómez, Alexandra Garcilazo-Reyes, Federico Avila-Moreno, et al.
Nature Communications|May 16, 2025
Alectinib in combination with bevacizumab as first-line treatment in ALK-rearranged non-small cell lung cancer (ALEK-B): a single-arm, phase 2 trialOscar Arrieta, Luis Lara-Mejía, Eduardo Rios-Garcia, et al.
Cirugia Y Cirujanos|October 20, 2025
Second Mexican Consensus on Endometrial CancerDavid F Cantú-de León, Flavia Morales-Vásquez, Claudia Cano-Blanco, et al.
Pageof 1

Showing results (1-10 of 4) with videos related to

Sort By:
Pageof 1
Oncology (Williston Park, N.Y.)|July 2, 2020
Which Larynx-Preservation Strategy Would Be Best for a Patient With Resectable, Locally Advanced, Hypopharynx Squamous Cell Carcinoma?Nora Sobrevilla-Moreno, Javier I Altamirano-Garcia, Martin Granados-Garcia, et al.
JCO Global Oncology|September 29, 2025
Cascade Testing Among Patients With Breast Cancer: Current Situation and Challenges in Latin AmericaRosa María Alvarez-Gómez, Alexandra Garcilazo-Reyes, Federico Avila-Moreno, et al.
Nature Communications|May 16, 2025
Alectinib in combination with bevacizumab as first-line treatment in ALK-rearranged non-small cell lung cancer (ALEK-B): a single-arm, phase 2 trialOscar Arrieta, Luis Lara-Mejía, Eduardo Rios-Garcia, et al.
Cirugia Y Cirujanos|October 20, 2025
Second Mexican Consensus on Endometrial CancerDavid F Cantú-de León, Flavia Morales-Vásquez, Claudia Cano-Blanco, et al.
Pageof 1